piperacillin has been researched along with Cytomegalovirus Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, TT; Chiu, CC; Lin, TC; Wu, RX; Yang, YS | 1 |
Chen, PL; Hung, YP; Ko, WC; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wu, CJ; Wu, YH; Yeh, FH | 1 |
2 other study(ies) available for piperacillin and Cytomegalovirus Infections
Article | Year |
---|---|
Recurrence of Cytomegalovirus Viremia Causing Gastrointestinal Tract Bleeding at Different Sites in an Immuno-competent Patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Transfusion; Colitis; Colon; Cytomegalovirus; Cytomegalovirus Infections; Diarrhea; Esomeprazole; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Humans; Immunocompetence; Male; Penicillanic Acid; Piperacillin; Pneumonia; Pulmonary Disease, Chronic Obstructive; Steroids; Tazobactam; Treatment Outcome; Viremia | 2017 |
Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Clostridium; Clostridium Infections; Cytomegalovirus Infections; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |